Status:
COMPLETED
Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy
Lead Sponsor:
Tabula Rasa HealthCare
Conditions:
COVID
Drug Effect
Eligibility:
All Genders
55+ years
Brief Summary
This retrospective study aims to perform a medication risk stratification using drug claims data and to simulate the impact of the addition of various repurposed drugs on the Medication Risk Score (MR...
Detailed Description
Certain investigational agents have been described in observational series or are being used anecdotally based on in vitro or extrapolated evidence. It is important to acknowledge that there are no co...
Eligibility Criteria
Inclusion
- Patient enrolled in a PACE organization during the implementation period;
- PACE organization contractually receiving pharmacy services from CareKinesis;
Exclusion
- No drug claims data available for the period of 2019-2020
Key Trial Info
Start Date :
April 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2023
Estimated Enrollment :
12873 Patients enrolled
Trial Details
Trial ID
NCT04339634
Start Date
April 2 2020
End Date
January 30 2023
Last Update
January 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute
Orlando, Florida, United States, 32827